Literature DB >> 26948928

Transcriptional and post-transcriptional regulation of NK cell development and function.

Jeffrey W Leong1, Julia A Wagner1, Aaron R Ireland1, Todd A Fehniger2.   

Abstract

Natural killer (NK) cells are specialized innate lymphoid cells that survey against viral infections and malignancy. Numerous advances have improved our understanding of the molecular mechanisms that control NK cell development and function over the past decade. These include both studies on the regulatory effects of transcription factors and translational repression via microRNAs. In this review, we summarize our current knowledge of DNA-binding transcription factors that regulate gene expression and thereby orchestrate NK cell development and activation, with an emphasis on recent discoveries. Additionally, we highlight our understanding of how RNA-binding microRNAs fine tune the NK cell molecular program. We also underscore the large number of open questions in the field that are now being addressed using new technological approaches and genetically engineered model organisms. Ultimately, a deeper understanding of the basic molecular biology of NK cells will facilitate new strategies to manipulate NK cells for the treatment of human disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Innate lymphoid cells; MicroRNAs; Molecular biology; NK cells; Transcription factors; mRNA

Mesh:

Substances:

Year:  2016        PMID: 26948928      PMCID: PMC5010797          DOI: 10.1016/j.clim.2016.03.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  154 in total

1.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.

Authors:  H Daniel Lacorazza; Yasushi Miyazaki; Antonio Di Cristofano; Anthony Deblasio; Cyrus Hedvat; Jin Zhang; Carlos Cordon-Cardo; Shifeng Mao; Pier Paolo Pandolfi; Stephen D Nimer
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1.

Authors:  T Fujita; Y Kimura; M Miyamoto; E L Barsoumian; T Taniguchi
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

4.  A role for Blimp1 in the transcriptional network controlling natural killer cell maturation.

Authors:  Axel Kallies; Sebastian Carotta; Nicholas D Huntington; Nicholas J Bernard; David M Tarlinton; Mark J Smyth; Stephen L Nutt
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

5.  Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

Authors:  Frank Cichocki; Martin Felices; Valarie McCullar; Steven R Presnell; Ahmad Al-Attar; Charles T Lutz; Jeffrey S Miller
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

6.  MicroRNAs activate natural killer cells through Toll-like receptor signaling.

Authors:  Shun He; Jianhong Chu; Lai-Chu Wu; Hsiaoyin Mao; Yong Peng; Christopher A Alvarez-Breckenridge; Tiffany Hughes; Min Wei; Jianying Zhang; Shunzong Yuan; Sumeet Sandhu; Sumithira Vasu; Don M Benson; Craig C Hofmeister; Xiaoming He; Kalpana Ghoshal; Steven M Devine; Michael A Caligiuri; Jianhua Yu
Journal:  Blood       Date:  2013-04-11       Impact factor: 22.113

Review 7.  Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function.

Authors:  Christine L Hershey; David E Fisher
Journal:  Bone       Date:  2004-04       Impact factor: 4.398

8.  Strain-dependent inhibitory effect of mutant mi-MITF on cytotoxic activities of cultured mast cells and natural killer cells of mice.

Authors:  Tatsuki R Kataoka; Eiichi Morii; Keisuke Oboki; Yukihiko Kitamura
Journal:  Lab Invest       Date:  2004-03       Impact factor: 5.662

9.  Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

Authors:  Emily M Mace; Amy P Hsu; Linda Monaco-Shawver; George Makedonas; Joshua B Rosen; Lesia Dropulic; Jeffrey I Cohen; Eugene P Frenkel; John C Bagwell; John L Sullivan; Christine A Biron; Christine Spalding; Christa S Zerbe; Gulbu Uzel; Steven M Holland; Jordan S Orange
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

10.  The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development.

Authors:  Stefania Crotta; Annita Gkioka; Victoria Male; João H Duarte; Sophia Davidson; Ilaria Nisoli; Hugh J M Brady; Andreas Wack
Journal:  J Immunol       Date:  2014-02-17       Impact factor: 5.422

View more
  14 in total

1.  MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells.

Authors:  Melissa M Berrien-Elliott; Yaping Sun; Carly Neal; Aaron Ireland; Maria C Trissal; Ryan P Sullivan; Julia A Wagner; Jeffrey W Leong; Pamela Wong; Annelise Y Mah-Som; Terrence N Wong; Timothy Schappe; Catherine R Keppel; Victor S Cortez; Efstathios G Stamatiades; Ming O Li; Marco Colonna; Daniel C Link; Anthony R French; Megan A Cooper; Wei-Le Wang; Mark P Boldin; Pavan Reddy; Todd A Fehniger
Journal:  Immunity       Date:  2019-08-08       Impact factor: 31.745

2.  MiR-30c facilitates natural killer cell cytotoxicity to lung cancer through targeting GALNT7.

Authors:  Fei Gao; Jianjun Han; Li Jia; Jun He; Yun Wang; Mi Chen; Xiaojun Liu; Xia He
Journal:  Genes Genomics       Date:  2022-08-30       Impact factor: 2.164

3.  HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR).

Authors:  Chang W Song; Hyunkyung Kim; Haeun Cho; Mi-Sook Kim; Sun-Ha Paek; Heon-Joo Park; Robert J Griffin; Stephanie Terezakis; Lawrence Chinsoo Cho
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

4.  Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.

Authors:  Bethany L Mundy-Bosse; Christoph Weigel; Yue-Zhong Wu; Salma Abdelbaky; Youssef Youssef; Susana Beceiro Casas; Nicholas Polley; Gabrielle Ernst; Karen A Young; Kathleen K McConnell; Ansel P Nalin; Kevin G Wu; Megan Broughton; Matthew R Lordo; Ekaterina Altynova; Everardo Hegewisch-Solloa; Daniel Y Enriquez-Vera; Daniela Dueñas; Carlos Barrionuevo; Shan-Chi Yu; Atif Saleem; Carlos J Suarez; Edward L Briercheck; Hernan Molina-Kirsch; Thomas P Loughran; Dieter Weichenhan; Christoph Plass; John C Reneau; Emily M Mace; Fabiola Valvert Gamboa; David M Weinstock; Yasodha Natkunam; Michael A Caligiuri; Anjali Mishra; Pierluigi Porcu; Robert A Baiocchi; Jonathan E Brammer; Aharon G Freud; Christopher C Oakes
Journal:  Blood Cancer Discov       Date:  2022-03-01

5.  An NK-like CAR T cell transition in CAR T cell dysfunction.

Authors:  Charly R Good; M Angela Aznar; Shunichiro Kuramitsu; Parisa Samareh; Sangya Agarwal; Greg Donahue; Kenichi Ishiyama; Nils Wellhausen; Austin K Rennels; Yujie Ma; Lifeng Tian; Sonia Guedan; Katherine A Alexander; Zhen Zhang; Philipp C Rommel; Nathan Singh; Karl M Glastad; Max W Richardson; Keisuke Watanabe; Janos L Tanyi; Mark H O'Hara; Marco Ruella; Simon F Lacey; Edmund K Moon; Stephen J Schuster; Steven M Albelda; Lewis L Lanier; Regina M Young; Shelley L Berger; Carl H June
Journal:  Cell       Date:  2021-12-02       Impact factor: 66.850

6.  Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development.

Authors:  Marcel Maluski; Arnab Ghosh; Jessica Herbst; Vanessa Scholl; Rolf Baumann; Jochen Huehn; Robert Geffers; Johann Meyer; Holger Maul; Britta Eiz-Vesper; Andreas Krueger; Axel Schambach; Marcel Rm van den Brink; Martin G Sauer
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 7.  Potential Roles of Peripheral Dopamine in Tumor Immunity.

Authors:  Xiang Zhang; Qiaofei Liu; Quan Liao; Yupei Zhao
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

8.  The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development.

Authors:  Mirte Post; Angelica Cuapio; Markus Osl; Dorit Lehmann; Ulrike Resch; David M Davies; Martin Bilban; Bernhard Schlechta; Wolfgang Eppel; Amit Nathwani; Dagmar Stoiber; Jan Spanholtz; Emilio Casanova; Erhard Hofer
Journal:  Front Immunol       Date:  2017-05-15       Impact factor: 7.561

Review 9.  Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.

Authors:  Hyung-Joon Kwon; Nayoung Kim; Hun Sik Kim
Journal:  Exp Mol Med       Date:  2017-03-31       Impact factor: 8.718

Review 10.  Immunomodulation of NK Cells by Ionizing Radiation.

Authors:  Jiarui Chen; Xingyu Liu; Zihang Zeng; Jiali Li; Yuan Luo; Wenjie Sun; Yan Gong; Junhong Zhang; Qiuji Wu; Conghua Xie
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.